Iluvien For Diabetic Macular Edema Turned Down By FDA

Investigational drug Iluvien (fluocinolone acetonide intravitreal insert) for the treatment of diabetic macular edema cannot be approved in its present form, the FDA (Food and Drug Administration) wrote in its Complete Response Letter (CRL). Illuven is the result of a collaboration between pSdivida Corp. and Alimera Sciences Inc…
Diabetes News From Medical News Today

Responses are currently closed, but you can trackback from your own site.

Comments are closed.

Copyright 2010 DiabetesSigns.org, Inc. All rights reserved. The material in this site is intended to be of general informational use and is not intended to constitute medical advice, probable diagnosis, or recommended treatments. See the Terms of Service for more information. Privacy Policy

Powered by Yahoo! Answers